TrialPloS one2020

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.

Gregory D Huhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.